Elsevier

European Urology

Volume 70, Issue 1, July 2016, Pages 106-119
European Urology

Platinum Priority – Guidelines
Editorial by Rodolfo Montironi, Liang Cheng, Marina Scarpelli and Antonio Lopez-Beltran on pp. 120–123 of this issue
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours

https://doi.org/10.1016/j.eururo.2016.02.028Get rights and content

Abstract

It has been 12 yr since the publication of the last World Health Organization (WHO) classification of tumours of the prostate and bladder. During this time, significant new knowledge has been generated about the pathology and genetics of these tumours. Intraductal carcinoma of the prostate is a newly recognized entity in the 2016 WHO classification. In most cases, it represents intraductal spread of aggressive prostatic carcinoma and should be separated from high-grade prostatic intraepithelial neoplasia. New acinar adenocarcinoma variants are microcystic adenocarcinoma and pleomorphic giant cell adenocarcinoma. Modifications to the Gleason grading system are incorporated into the 2016 WHO section on grading of prostate cancer, and it is recommended that the percentage of pattern 4 should be reported for Gleason score 7. The new WHO classification further recommends the recently developed prostate cancer grade grouping with five grade groups. For bladder cancer, the 2016 WHO classification continues to recommend the 1997 International Society of Urological Pathology grading classification. Newly described or better defined noninvasive urothelial lesions include urothelial dysplasia and urothelial proliferation of uncertain malignant potential, which is frequently identified in patients with a prior history of urothelial carcinoma. Invasive urothelial carcinoma with divergent differentiation refers to tumours with some percentage of “usual type” urothelial carcinoma combined with other morphologies. Pathologists should mention the percentage of divergent histologies in the pathology report.

Patient summary

Intraductal carcinoma of the prostate is a newly recognized entity in the 2016 World Health Organization classification. Better defined noninvasive urothelial lesions include urothelial dysplasia and urothelial proliferation of uncertain malignant potential.

Section snippets

The new prostate tumour classification

The aim of this review is to summarize the new additions to the 2016 World Health Organization (WHO) classification (WHO “blue book”) compared with the 2004 WHO classification, with emphasis on a new entity, new variants of acinar adenocarcinoma, and new imunohistochemical stains for diagnosis, grading, risk stratification, and molecular genetics of acinar adenocarcinoma of the prostate. The 2016 WHO classification of tumours of the prostate [1] is summarized in Figure 1.

The new bladder tumour classification

The fourth edition of the WHO classification of tumours of the urothelial tract provides a contemporary review of the morphology of urothelial neoplasms, emphasizing their unique ability to exhibit divergent differentiation, multiple morphologic variants, and a diverse genomic landscape (Fig. 4) [1]. It is becoming clearer how both morphology and genotype may be exploited to select therapy, and for the latter, clinical protocols are in place to take advantage of activated molecular pathways in

References (136)

  • J.I. Epstein

    The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?

    Crit Rev Oncol Hematol

    (2003)
  • T.D. Jones et al.

    Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts

    J Urol

    (2006)
  • R. Montironi et al.

    Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network

    Eur Urol

    (2002)
  • M.B. Amin et al.

    ICUD-EAU International Consultation on Bladder Cancer 2012: pathology

    Eur Urol

    (2013)
  • M.B. Amin et al.

    Update for the practicing pathologist: the International Consultation on Urologic Disease-European Association of Urology consultation on bladder cancer

    Mod Pathol

    (2015)
  • A. Hartmann et al.

    Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma

    Am J Pathol

    (1999)
  • N. Readal et al.

    Papillary urothelial hyperplasia: relationship to urothelial neoplasms

    Pathology.

    (2010)
  • G. Dalbagni et al.

    Cystectomy for bladder cancer: a contemporary series

    J Urol

    (2001)
  • B.J. Linder et al.

    Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis

    J Urol

    (2013)
  • S.P. Kim et al.

    The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma

    J Urol

    (2012)
  • E. Xylinas et al.

    Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy

    Eur J Cancer

    (2013)
  • C.C. Guo et al.

    Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases

    Hum Pathol

    (2009)
  • H. Ikegami et al.

    Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients

    Hum Pathol

    (2000)
  • E.B. Blochin et al.

    Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection

    Mod Pathol

    (2012)
  • M.S. Zaghloul et al.

    Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients

    Urol Oncol

    (2006)
  • O. Lin et al.

    Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases

    Mod Pathol

    (2003)
  • R.H. Young et al.

    Unusual forms of carcinoma of the urinary bladder

    Hum Pathol

    (1991)
  • E. Comperat et al.

    Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases

    Pathology

    (2010)
  • M. Spaliviero et al.

    Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder

    J Urol

    (2014)
  • S.A. Schneider et al.

    Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome

    Mod Pathol

    (2014)
  • H.Z. Kaimakliotis et al.

    Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes

    Urology

    (2014)
  • R.R. Ricardo-Gonzalez et al.

    Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread

    J Urol

    (2012)
  • F. Dayyani et al.

    Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis

    J Urol

    (2013)
  • N.D. Gonzalez-Roibon et al.

    Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder

    Hum Pathol

    (2013)
  • P.A. Drew et al.

    The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature

    Hum Pathol

    (1996)
  • H. Moch et al.

    WHO Classification of Tumours of the Urinary System and Male Genital Organs

    (2016)
  • J. Kovi et al.

    Ductal spread in prostatic carcinoma

    Cancer

    (1985)
  • M. Magers et al.

    Intraductal carcinoma of the prostate: morphologic features, differential diagnoses, significance, and reporting practices

    Arch Pathol Lab Med

    (2015)
  • J.E. McNeal et al.

    Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations

    Am J Surg Pathol

    (1996)
  • T. Tsuzuki

    Intraductal carcinoma of the prostate: a comprehensive and updated review

    Int J Urol

    (2015)
  • B. Robinson et al.

    Intraductal carcinoma of the prostate

    Arch Pathol Lab Med

    (2012)
  • K. Watts et al.

    Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study

    Histopathology

    (2013)
  • K. Miyai et al.

    Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between “precursor-like” and “regular type” lesions

    Int J Clin Exp Pathol

    (2014)
  • C.L. Morais et al.

    Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy

    Am J Surg Pathol

    (2015)
  • P.A. Humphrey

    Histological variants of prostatic carcinoma and their significance

    Histopathology

    (2012)
  • O. Yaskiv et al.

    Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns

    Am J Surg Pathol

    (2010)
  • A.V. Parwani et al.

    Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases

    Am J Surg Pathol

    (2006)
  • A. Lopez-Beltran et al.

    Pleomorphic giant cell carcinoma of the prostate

    Arch Pathol Lab Med

    (2005)
  • A.J. Evans et al.

    Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer

    Am J Surg Pathol

    (2006)
  • J.I. Epstein et al.

    Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference

    Am J Surg Pathol

    (2014)
  • Cited by (1099)

    View all citing articles on Scopus
    View full text